Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Voltage-gated potassium channel proteins and stereoselective S-nitroso-l-cysteine signaling
Benjamin Gaston, Laura Smith, Jürgen Bosch, James Seckler, Diana Kunze, Janna Kiselar, Nadzeya Marozkina, Craig A. Hodges, Patrick Wintrobe, Kellen McGee, Tatiana S. Morozkina, Spencer T. Burton, Tristan Lewis, Timothy Strassmaier, Paulina Getsy, James N. Bates, Stephen J. Lewis
Benjamin Gaston, Laura Smith, Jürgen Bosch, James Seckler, Diana Kunze, Janna Kiselar, Nadzeya Marozkina, Craig A. Hodges, Patrick Wintrobe, Kellen McGee, Tatiana S. Morozkina, Spencer T. Burton, Tristan Lewis, Timothy Strassmaier, Paulina Getsy, James N. Bates, Stephen J. Lewis
View: Text | PDF
Research Article Cell biology

Voltage-gated potassium channel proteins and stereoselective S-nitroso-l-cysteine signaling

  • Text
  • PDF
Abstract

S-nitroso-l-cysteine (L-CSNO) behaves as a ligand. Its soluble guanylate cyclase–independent (sGC-independent) effects are stereoselective — that is, not recapitulated by S-nitroso-d-cysteine (D-CSNO) — and are inhibited by chemical congeners. However, candidate L-CSNO receptors have not been identified. Here, we have used 2 complementary affinity chromatography assays — followed by unbiased proteomic analysis — to identify voltage-gated K+ channel (Kv) proteins as binding partners for L-CSNO. Stereoselective L-CSNO–Kv interaction was confirmed structurally and functionally using surface plasmon resonance spectroscopy; hydrogen deuterium exchange; and, in Kv1.1/Kv1.2/Kvβ2-overexpressing cells, patch clamp assays. Remarkably, these sGC-independent L-CSNO effects did not involve S-nitrosylation of Kv proteins. In isolated rat and mouse respiratory control (petrosyl) ganglia, L-CSNO stereoselectively inhibited Kv channel function. Genetic ablation of Kv1.1 prevented this effect. In intact animals, L-CSNO injection at the level of the carotid body dramatically and stereoselectively increased minute ventilation while having no effect on blood pressure; this effect was inhibited by the L-CSNO congener S-methyl-l-cysteine. Kv proteins are physiologically relevant targets of endogenous L-CSNO. This may be a signaling pathway of broad relevance.

Authors

Benjamin Gaston, Laura Smith, Jürgen Bosch, James Seckler, Diana Kunze, Janna Kiselar, Nadzeya Marozkina, Craig A. Hodges, Patrick Wintrobe, Kellen McGee, Tatiana S. Morozkina, Spencer T. Burton, Tristan Lewis, Timothy Strassmaier, Paulina Getsy, James N. Bates, Stephen J. Lewis

×

Figure 3

L-CSNO binding to Kv proteins.

Options: View larger image (or click on image) Download as PowerPoint
L-CSNO binding to Kv proteins.
L-CSNO has unique binding interactions wi...
L-CSNO has unique binding interactions with the intracellular Kv proteins Kv1.1α T1 (A–E) and Kvβ2 (F) (see also Supplemental Figure 3). (A) The SPR binding response of L-CSNO, D-CSNO, or l-cysteine to Kv1.1α T1. The binding isotherm for each protein-ligand interaction is represented in the inset of each graph. n = 25 measurements each. Data are mean ± SEM.(B) CD analysis of Kv1.1α T1 in the presence of increasing amounts of L-CSNO and D-CSNO. n = 7 measurements each. (C) Secondary structure changes of Kv1.1α T1 upon titration with L-CSNO or D-CSNO. (D) Substrate stereoselectivity and thermal stability of Kv1.1α T1. Melting temperature increases by 20°C upon L-CSNO binding to Kv1.1α T1. km, Michaelis constant; ka, association constant; kd, dissociation constant; KD, affinity. (E) Differential deuterium uptake after a 15 minute pulse between the unliganded Kvβ and in solution with L-CSNO, D-CSNO, l-cysteine, or EtONO. Blue peptides represent a greater than 20% rigidification; green peptides represent between 0% and 20% rigidification. (F) Differential deuterium uptake after a 1 minute pulse between the unliganded Kv1.1α T1 and in solution with L-CSNO, D-CSNO, or l-cysteine. Blue peptides represent a greater than 20% rigidification. Green peptides represent between 0% and 20% rigidification, and gray peptides represent no significant rigidification. NADPH is shown in teal spheres.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts